OBJECTIVE: To assess the relation between self reported intensity and frequency of stress and first time incidence of primary breast cancer. DESIGN: Prospective cohort study with 18 years of follow-up. SETTING: Copenhagen City heart study, Denmark. PARTICIPANTS: The 6689 women participating in the Copenhagen City heart study were asked about their perceived level of stress at baseline in 1981-3. These women were followed until 1999 in the Danish nationwide cancer registry, with < 0.1% loss to follow-up. MAIN OUTCOME MEASURE: First time incidence of primary breast cancer. RESULTS: During follow-up 251 women were diagnosed with breast cancer. After adjustment for confounders, women with high levels of stress had a hazard ratio of 0.60 (95% confidence interval 0.37 to 0.97) for breast cancer compared with women with low levels of stress. Furthermore, for each increase in stress level on a six point stress scale an 8% lower risk of primary breast cancer was found (hazard ratio 0.92, 0.85 to 0.99). This association seemed to be stable over time and was particularly pronounced in women receiving hormone therapy. CONCLUSION: High endogenous concentrations of oestrogen are a known risk factor for breast cancer, and impairment of oestrogen synthesis induced by chronic stress may explain a lower incidence of breast cancer in women with high stress. Impairment of normal body function should not, however, be considered a healthy response, and the cumulative health consequences of stress may be disadvantageous.
OBJECTIVE: To assess the relation between self reported intensity and frequency of stress and first time incidence of primary breast cancer. DESIGN: Prospective cohort study with 18 years of follow-up. SETTING: Copenhagen City heart study, Denmark. PARTICIPANTS: The 6689 women participating in the Copenhagen City heart study were asked about their perceived level of stress at baseline in 1981-3. These women were followed until 1999 in the Danish nationwide cancer registry, with < 0.1% loss to follow-up. MAIN OUTCOME MEASURE: First time incidence of primary breast cancer. RESULTS: During follow-up 251 women were diagnosed with breast cancer. After adjustment for confounders, women with high levels of stress had a hazard ratio of 0.60 (95% confidence interval 0.37 to 0.97) for breast cancer compared with women with low levels of stress. Furthermore, for each increase in stress level on a six point stress scale an 8% lower risk of primary breast cancer was found (hazard ratio 0.92, 0.85 to 0.99). This association seemed to be stable over time and was particularly pronounced in women receiving hormone therapy. CONCLUSION: High endogenous concentrations of oestrogen are a known risk factor for breast cancer, and impairment of oestrogen synthesis induced by chronic stress may explain a lower incidence of breast cancer in women with high stress. Impairment of normal body function should not, however, be considered a healthy response, and the cumulative health consequences of stress may be disadvantageous.
Authors: Anne Helene Olsen; Sisse H Njor; Ilse Vejborg; Walter Schwartz; Peter Dalgaard; Maj-Britt Jensen; Ulla Brix Tange; Mogens Blichert-Toft; Fritz Rank; Henning Mouridsen; Elsebeth Lynge Journal: BMJ Date: 2005-01-13
Authors: Thomas P Ahern; Katalin Veres; Tammy Jiang; Dóra Körmendiné Farkas; Timothy L Lash; Henrik Toft Sørensen; Jaimie L Gradus Journal: Acta Oncol Date: 2018-04-24 Impact factor: 4.089
Authors: Lauren A Wise; Julie R Palmer; Deborah A Boggs; Lucile L Adams-Campbell; Lynn Rosenberg Journal: Cancer Causes Control Date: 2011-02-13 Impact factor: 2.506
Authors: Yvonne L Michael; Nichole E Carlson; Rowan T Chlebowski; Mikel Aickin; Karen L Weihs; Judith K Ockene; Deborah J Bowen; Cheryl Ritenbaugh Journal: Health Psychol Date: 2009-03 Impact factor: 4.267
Authors: Marta Falcinelli; Premal H Thaker; Susan K Lutgendorf; Suzanne D Conzen; Renée L Flaherty; Melanie S Flint Journal: Cancer Res Date: 2021-07-15 Impact factor: 12.701
Authors: Katriina Heikkilä; Solja T Nyberg; Töres Theorell; Eleonor I Fransson; Lars Alfredsson; Jakob B Bjorner; Sébastien Bonenfant; Marianne Borritz; Kim Bouillon; Herman Burr; Nico Dragano; Goedele A Geuskens; Marcel Goldberg; Mark Hamer; Wendela E Hooftman; Irene L Houtman; Matti Joensuu; Anders Knutsson; Markku Koskenvuo; Aki Koskinen; Anne Kouvonen; Ida E H Madsen; Linda L Magnusson Hanson; Michael G Marmot; Martin L Nielsen; Maria Nordin; Tuula Oksanen; Jaana Pentti; Paula Salo; Reiner Rugulies; Andrew Steptoe; Sakari Suominen; Jussi Vahtera; Marianna Virtanen; Ari Väänänen; Peter Westerholm; Hugo Westerlund; Marie Zins; Jane E Ferrie; Archana Singh-Manoux; G David Batty; Mika Kivimäki Journal: BMJ Date: 2013-02-07